ZBIO
Zenas BioPharma, Inc.
28.70
+0.12 (+0.42%)
52w low 13.50
44.60 high
48.9% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 67.21M | 56.86M | 319.74M | 110.64M | |
| Current Assets | 68.44M | 59.80M | 355.92M | 351.17M | |
| Net PP&E | 1.80M | 1.01M | 1.19M | 1.39M | |
| Total Assets | 74.58M | 68.18M | 369.97M | 383.64M | |
| Current Liabilities | 25.97M | 23.26M | 57.29M | 62.65M | |
| Total Debt | 1.53M | 21.11M | 1.00M | 1.33M | |
| Total Liabilities | 266.87M | 293.90M | 57.51M | 141.50M | |
| Retained Earnings | -193.28M | -230.40M | -387.39M | -765.13M | |
| Shareholders Equity | -192.29M | -225.72M | 312.46M | 242.14M | |
| Working Capital | 42.48M | 36.55M | 298.63M | 288.52M | |
| Shares Outstanding | 39.79M | 39.79M | 41.79M | 54.49M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+100.0%